- Home
- TEVA
as 06-18-2025 10:00am EST
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
| Founded: | 1901 | Country: | Israel |
| Employees: | N/A | City: | TEL AVIV |
| Market Cap: | 20.1B | IPO Year: | N/A |
| Target Price: | $25.00 | AVG Volume (30 days): | 11.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.46 - $22.80 | Next Earning Date: | 07-30-2025 |
| Revenue: | $16,616,000,000 | Revenue Growth: | 3.82% |
| Revenue Growth (this year): | 5.69% | Revenue Growth (next year): | N/A |
Latest Teva Pharmaceutical Industries Limited News
TEVA Breaking Stock News: Dive into TEVA Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy
The Wall Street Journal
a day ago
Generic Drugmakers Resist Trump’s Calls for More U.S. Manufacturing
TipRanks
a day ago
Teva, Fosun Pharma partner to develop TEV-56278
Pharmaceutical Technology
a day ago
Teva to collaborate with Fosun Pharma for TEV-56278
MT Newswires
2 days ago
Teva Pharmaceutical Industries Insider Sold Shares Worth $952,464, According to a Recent SEC Filing
MT Newswires
2 days ago
Teva Pharmaceutical, Shanghai Fosun Partner to Develop Cancer Treatment Drug
GlobeNewswire
2 days ago
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
Motley Fool
2 days ago
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters
Compare TEVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEVA Teva Pharmaceutical Industries Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.